DaShenLin Pharmaceutical Group Co., Ltd. (SHA:603233)
15.96
+0.07 (0.44%)
Jun 27, 2025, 2:45 PM CST
SHA:603233 Market Cap
SHA:603233 has a market cap or net worth of 18.03 billion as of June 27, 2025. Its market cap has decreased by -28.85% in one year.
Market Cap
18.03B
Enterprise Value
19.40B
Revenue
26.70B
Ranking
n/a
PE Ratio
18.36
Stock Price
15.96
Market Cap Chart
Since July 31, 2017, SHA:603233's market cap has increased from 14.24B to 18.03B, an increase of 26.60%. That is a compound annual growth rate of 3.04%.
Market Capitalization
Market capitalization, also called net worth, is the total value of all of a company's outstanding shares. It is calculated by multiplying the stock price by the number of shares outstanding.
Formula: Market Cap = Stock Price * Shares Outstanding
Full DefinitionRelated Stocks
Company | Market Cap |
---|---|
Jiangsu Hengrui Medicine | 344.23B |
Shenzhen Mindray Bio-Medical Electronics | 275.14B |
WuXi AppTec | 189.25B |
Zhangzhou Pientzehuang Pharmaceutical., | 120.95B |
Sichuan Biokin Pharmaceutical | 119.30B |
Aier Eye Hospital Group | 115.27B |
Shanghai United Imaging Healthcare | 105.13B |
Yunnan Baiyao Group Co.,Ltd | 99.70B |